This very thorough analysis of the Senegalese Antiretroviral Drug Access Initiative (ISAARV) presents preliminary results from the initiative's first three years. The analysis explores four aspects of the programme: treatment access, adherence, therapeutic efficacy, and the impact of this treatment programme on the Senegalese health care system